Institutional
Ally Bridge Group (NY) LLC
CIK 0001822947
$123.8M
Reported AUM
26
Positions
Q1 2026
Period
2026-05-18
Filed
The Brief · Ally Bridge Group (NY) LLC · Q1 2026
AI · grounded in 13F
Ally Bridge Group (NY) LLC closed its position in ATAI BECKLEY NV, reducing exposure by $7,006,599. The fund established new positions in TARS for $5,672,259 and CMPX for $5,290,000. Other activity included closing its position in TSHA for $5,264,226 and increasing its share count in SLNO by 138.05%.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SLNO | SOLENO THERAPEUTICS INC | — | — | — | — | $13.4M | 10.82% | — | HELD |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | $307.75 | 5.75% | 453.36% | 0.42% | $10.6M | 8.54% | — | HELD |
| 3 | NERV | MINERVA NEUROSCIENCES INC | $4.02 | -1.71% | 110.14% | -72.69% | $10.0M | 8.06% | — | HELD |
| 4 | OVID | OVID THERAPEUTICS INC | $2.37 | 3.49% | 374.00% | -32.86% | $6.3M | 5.05% | — | HELD |
| 5 | CMPS | COMPASS PATHWAYS PLC | $11.57 | 6.15% | 166.59% | -65.87% | $5.8M | 4.67% | — | HELD |
| 6 | TARS | TARSUS PHARMACEUTICALS INC | $59.54 | 1.74% | 43.71% | 121.32% | $5.7M | 4.58% | — | HELD |
| 7 | SLDB | SOLID BIOSCIENCES INC | $8.49 | 5.60% | 24.30% | -79.11% | $5.5M | 4.46% | — | HELD |
| 8 | CMPX | COMPASS THERAPEUTICS INC | $1.94 | 0.00% | -34.41% | -44.71% | $5.3M | 4.27% | — | HELD |
| 9 | PMN | PROMIS NEUROSCIENCES INC | $14.92 | 6.12% | -22.49% | -93.78% | $5.3M | 4.25% | — | HELD |
| 10 | EWTX | EDGEWISE THERAPEUTICS INC | $41.12 | 3.45% | 177.78% | 150.95% | $5.1M | 4.10% | — | HELD |
| 11 | QURE | UNIQURE NV | $42.19 | 5.29% | 201.90% | 42.57% | $4.9M | 3.96% | — | HELD |
| 12 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $6.55 | 9.72% | 16.54% | 126.20% | $4.8M | 3.86% | — | HELD |
| 13 | CTMX | CYTOMX THERAPEUTICS INC. | $3.28 | 3.47% | 37.02% | -37.11% | $4.2M | 3.42% | — | HELD |
| 14 | IVA | INVENTIVA SA | $4.62 | 2.44% | 42.55% | -65.23% | $4.1M | 3.34% | — | HELD |
| 15 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.99 | 4.18% | -18.75% | -53.28% | $3.9M | 3.12% | — | HELD |
| 16 | ABVX | ABIVAX SA | $124.33 | 4.62% | 72.81% | 1124.93% | $3.8M | 3.03% | — | HELD |
| 17 | ALMS | ALUMIS INC | $28.95 | 9.74% | 563.92% | 122.93% | $3.7M | 2.97% | — | HELD |
| 18 | URGN | UROGEN PHARMA LTD | $41.09 | 1.58% | 110.95% | 132.26% | $3.6M | 2.94% | — | HELD |
| 19 | CAPR | CAPRICOR THERAPEUTICS INC | $4.19 | -36.23% | -46.96% | -16.37% | $3.5M | 2.80% | — | HELD |
| 20 | MAZE | MAZE THERAPEUTICS INC | $27.63 | 1.32% | 85.44% | 125.92% | $3.0M | 2.41% | — | HELD |
| 21 | WHWK | WHITEHAWK THERAPEUTICS INC | $3.85 | 5.19% | 121.26% | -85.22% | $2.8M | 2.28% | — | HELD |
| 22 | IKT | INHIBIKASE THERAPEUTICS INC | $2.28 | 3.17% | 50.00% | -83.97% | $2.2M | 1.80% | — | HELD |
| 23 | REPL | REPLIMUNE GROUP INC | — | — | -28.82% | -82.97% | $1.9M | 1.53% | — | HELD |
| 24 | ANTX | AN2 THERAPEUTICS INC | $5.33 | 6.18% | 402.83% | -65.90% | $1.8M | 1.45% | — | HELD |
| 25 | RLMD | RELMADA THERAPEUTICS INC | $5.35 | 4.09% | 799.15% | -77.81% | $1.5M | 1.18% | — | HELD |
| 26 | KPTI | KARYOPHARM THERAPEUTICS INC | $7.01 | 2.19% | 78.37% | -91.94% | $1.4M | 1.12% | — | HELD |
Source: SEC EDGAR · accession 0001193125-26-227559. 13F discloses long positions only — shorts, foreign equities, and options are excluded.